Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Investigation of Alternative Ofatumumab-containing Regimens in Less Fit Patients With CLL

NCT01678430 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT01678430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01678430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Investigation of Alternative Ofatumumab-containing Regimens in Less Fit Patients With CLL
Lead sponsor
University of Liverpool
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2011
Completion date
December 31, 2017
Enrollment
670 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukaemia